Abstract
Inclusion of a chapter on tumor immunotherapy in this handbook may be premature or may reflect an optimistic assessment of its future clinical potential. However, the subject is relevant to a consideration of both antineoplastic and immunosuppressive agents because (a) immunotherapy is most effective as an adjunct to other modes of therapy which may be, or indeed may have to be, immunosuppressive and (b) it is likely that the therapeutic results obtained with drugs, x-irradiation, and/or surgery represent the end result, not only of their antitumor activity, but also the degree to which they do or do not affect the host’s immunologic response to residual tumor cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albo, V., Keivit, W., Hartmann, J.: Fresh plasma as an adjuvant to the chemotherapy of acute lymphatic leukemia in children. Proc. Amer. Ass. Cancer Res. 9, 2 (1968).
Alexander, P.: Immunotherapy of cancer. Experiments with primary tumors and syngeneic tumor grafts. Progr. exp. Tumor Res. 10, 22–71 (1968).
Alexander, P.: Immunological aspects of cancer — II. Prospects for immunotherapy of cancer. Experience in experimental systems. Brit. med. J. 4, 484–486 (1970).
Alexander, P., Connell, D.I., Miktrlska, Z.B.: Treatment of a murine leukemia with spleen cells or sera from allogeneic mice immunized against the tumor. Cancer Res. 26, 1508–1515 (1966).
Alexander, P., Hall, J.G.: The role of immunoblasts in host resistance and immunotherapy of primary sarcomata. Adv. Cancer Res. 13, 1–37 (1970).
Alexander, P., Hamdlton, L.D., Hall, J. G.: Effect of nucleic acids from immune lymphocytes on rat sarcomata. Nature (Lond.) 213, 509–511 (1967).
Allen, D.W., Cole, P.: Viruses and human cancer. New Engl. J. Med. 286, 70–82 (1972).
Allison, A.C.: Immunological aspects of cancer — part I. Potentiation of viral carcinogenesis by immunosuppression. Brit. med. J. 4, 419–420 (1970).
Allison, A.C.: New cell antigens induced by viruses and their biological significance. Proc. Roy. Soc. (Lond.) B, 177, 23–39 (1971).
Amiel, J.L.: Immunothérapie active non spécifique par le B.C.G. de la leucémie virale E G2 chez des receveurs isogénique. Rév. Fránc. Étude, clin. Biol. 12, 912–914 (1967).
Amiel, J.L., Berardet, M.: An experimental model of active immunotherapy preceded by cytoreductive chemotherapy. Europ. J. Cancer 6, 557–559 (1970).
Amiel, J.L., Berardet, M.: Essais de traitements de la leucémie E G2 associant chimio-thérapie et immunothérapies actives non spécifique et spécifique. Rév. Franc. Étud. clin. Biol. 14, 685–688 (1969).
Andrews, G.A., Congdon, C.C., Edwards, C.L., Gengozian, N., Nelson, B., Vodopick, H.: Preliminary trials of clinical immunotherapy. Cancer Res. 27, 2535–2541 (1967).
Apffel, C.A., Arnasson, B.G., Peters, J.H.: Induction of tumor immunity with tumor cells treated with iodoacetate. Nature (Lond.) 209, 694–696 (1966).
Attia, M.A.M., Weiss, D.W.: Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice injected with mammary tumor virus. Cancer Res. 26, 1787–1800 (1966).
Aust, J.C., Jagarlamoody, S., McKhann, C.F.: Immunization of lymphocytes in vitro for immunotherapy of malignant disease. Surg. Forum 21, 118–120 (1970).
Bagshawe, K.D., Currie, G.A.: Immunogenicity of L1210 murine leukemia cells after treatment with neuraminidase. Nature (Lond.) 218, 1254–1255 (1968).
Baldwin, R. W., Barker, C. R.: Antigenic composition of transplanted rat hepatomas originally induced by 4-dimethylaminoazobenzene. Brit. J. Cancer 21, 338–345 (1967).
Balme, R.H., Dockerty, M.B., Grindlay, J.H., Lrrzow, T.J.: The use of immune lymph in the treatment of mouse cancer. Minnesota Med. 45, 892–899 (1962).
Bansal, S.C., Hargreaves, R., Sjogren, H. O.: Facilitation of polyoma tumor growth in rats by blocking sera and tumor eluate. Int. J. Cancer 9, 97–108 (1972).
Bansal, S.C., Sjogren, H.O.: “Unblocking” serum activity in vitro in the polyoma system may correlate with antitumour effects of antiserum in vivo. Nature (Lond.) 233, 76–78 (1971).
Bard, D.S., Pilch, Y.H.: The role of the spleen in the immunity to a chemically induced sarcoma in C3H mice. Cancer Res. 29, 1125–1131 (1969).
Barnes, D.W.H., Loutit, J.F.: Treatment of murine leukemia with x-rays and homologous bone marrow. Brit. J. Hemat. 3, 241–252 (1957).
Barnes, D.W.H., Loutit, J.F., Neal, F.E.: Treatment of murine leukemia with x-rays and homologous bone marrow. Brit. med. J. 2, 626–630 (1956).
Bekesi, J.G., Arneault, G.S., Holland, J.F.: Increase of leukemia L1210 immunogenicity by vibrio cholerae neuraminidase treatment. Cancer Res. 31, 2130–2132 (1971).
Bernstein, I.D., Thor, D.E., Zbar, B., Rapp, H.J.: Tumor immunity. Tumor suppression in vivo initiated by soluble products of specifically stimulated lymphocytes. Science 172, 729–731 (1971).
Biozzi, G., Stiffel, C., Halpern, B.N., Motjton, D.: Effect de l’inoculation du Bacille de Calmette-Guerin sur le development de la tumeur ascitique d’Ehrlich chez la souris. C. R. Soc. Biol. (Paris) 153, 987–989 (1959).
Bonmassar, E., Vadlamudi, S., Vieira, V., Goldin, A.: Influence of Tween 80 on the antileukemic activity of I., 3-bis(2-chloroethyl)-l-nitrosourea. Arch. Ital. Patol. clin. Tumori 12, 163–175 (1969).
Bonneau, H., Cochet, G., Favre, R., Meyer, G.: Essai d’un traitement immunitaire par extraits tumoraux irradiés aux rayons u.v. des tumeurs de hamster à virus polyome. Bull. Cancer (Paris) 57, 55–68 (1970a).
Bonneau, H., Peyronel, J.C., Favre, R., Robert-Vague, D.: Essais de traitement auxiliaire de certains cancers humains par injections d’extraits tumoraux autologues irradiés aux rayons ultra-violets. Bull. Cancer (Paris) 57, 69–78 (1970b).
Boone, C., Blackman, K., Brandchaft, P.: Tumour immunity induced in mice with cell-free homogenates of influenza virus-infected tumor cells. Nature (Lond.) 231, 265–266 (1971).
Borani, C. M.: Transient graft-versus-host reaction in the treatment of leukemia in mice. J. nat. Cancer Inst. 41, 421–437 (1968).
Borani, C. M., Tonkovi, C. L: Time pattern of the antileukemic effect of the graft-versus-host reaction in mice. Cancer Res. 31, 1140–1147 (1970).
Bortin, M.: A compendium of reported human bone marrow transplants. Transplantation 9, 571–587 (1971).
Boyse, E.A., Old, L.J., Stockert, E.: Immunological enhancement of a leukemia. Nature (Lond.) 194, 1142–1144 (1962).
Brandes, L. J., Galton, D. A.G., Wiltshaw, E.: New approach to immunotherapy of melanoma. Lancet 2, 293–295 (1971).
Bubenik, J., Koldovsky, P.: Factors influencing the induction of enhancement and resistance to methylcholanthrene-induced tumors in a syngeneic system. Folio biol. (Praha) 11, 258–265 (1965).
Bubenik, J., Perlmann, P., Helmstein, K., Moberger, G.: Cellular and humoral immune responses to human urinary bladder carcinomas. Int. J. Cancer 5, 310–319 (1970).
Bubenik, J., Turano, A.: Enhancing effect on tumor growth of humoral antibodies against TSTA in tumors induced by murine sarcoma virus (Harvey). Nature (Lond.) 220, 928–930 (1968).
Bubenik, J., Turano, A., Fadda, G.: Prevention of carcinogenesis by murine sarcoma virus (Harvey) following injection of immune sera during the latency period. Int. J. Cancer 4, 648–654 (1969).
Buckner, C.D., Johnson, F.L., Thomas, E.D., Storb, R., Clift, R.A., Chard, R.L., Funk, D.D., Neiman, P., Fefer, A.: Allogeneic marrow grafting in acute lymphoblastic leukemia during marrow remission. Biomedicine 18, 295–303, 1973.
Burchenal, J.H., Oettgen, H.F., Holmberg, E.A.D., Hemphill, S.C., Reppert, J.A.: Effect of total body irradiation on the transplantability of mouse leukemia. Cancer Res. 20, 425–430 (1960).
Burkitt, D.: Clinical evidence suggesting the development of an immunological response against African lymphoma. UICC Monogr. Ser. 8, 197–203 (1967).
Burnet, F.M.: Implications of immunological surveillance for cancer therapy. Israel J. med. Sci. 7, 9–16 (1971).
Casazza, A.M., DiMarco, A., Dicuonzo, G.: Interference of Daunomycin and Adriamycin on the growth and regression of murine sarcoma virus (Moloney) tumors in mice. Cancer Res. 31, 1971–1976 (1971).
Cater, D.B., Waldmann, H.: The effect on the growth of BP8 ascites tumour in C3H/C57F1 or C3H mice of “lymphocyte preparations” from C57 mice injected with BP8 cells and Freund’s adjuvant. Brit. J. Cancer 21, 124–136 (1967).
Chang, S.S., Hildemann, W.H., Rasmussen, A.F., Jr.: Immunogenetic aspects of polyoma virus susceptibility in mice. J. nat. Cancer Inst. 40, 363–375 (1968).
Check, J.H., Childs, T.C., Brady, L.W., Derasse, A.R., Fuscaldo, K.E.: Protection against spontaneous mouse mammary adenocarcinoma by inoculation of heat-treated syngeneic mammary tumor cells. Int. J. Cancer 7, 403–408 (1971).
Clift, R.A., Buckneb, CD., Fefeb, A., Lebneb, K.G., Neiman, P.E., Stobb, R., Mubphy, M., Thomas, E.D.: Infectious complications of marrow transplantation. Transpl. ProC., 1973.
Cohen, I.R., Globebson, A., Feldman, M.: Rejection of tumor allografts by mouse spleen cells sensitized in vitro. J. exp. Med. 133, 821–833 (1971).
Congdon, C.C.: Cooperative group on bone marrow transplantation in man. Transpl. Proc. 2, 342–360 (1970).
Costachel, O., Iosub, A., Gutulescu, N., Mogos, I., Liciu, F.: Our experience in associated immunotherapy of cancer. Arch. Geschwulstforsch. 37, 19–32 (1971).
Cbowtheb, D.: Treatment of acute myelogenous leukemia in adults. Brit. J. Hematol. 21, 360–361 (1971).
Cunningham, T. J., Olson, K.B., Laffin, R., Hobton, J., Sullivan, J.: Treatment of advanced cancer with active immunization. Cancer 24, 932–937 (1969).
Cuebie, G.A., Bagshawe, K.D.: Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas. Brit. med. J. 1, 541–544 (1970).
Cubbie, G.A., Bagshawe, K.D.: Tumor-specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase. Brit. J. Cancer 23, 141–149 (1969).
Cubbie, G.A., Lejeune, F., Faibley, G.H.: Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Brit. med. J. 2, 305–310 (1971).
Czajkowski, N.P., Rosenblatt, M., Cushing, F.R., Vazquez, J., Wolf, P.L.: Production of active immunity to malignant neoplastic tissue. Cancer 19, 739–749 (1966).
Czajkowski, N.P., Rosenblatt, M., Wolf, P.L., Vazquez, J.: A method of active immunization to autologous human tumor tissue. Lancet 2, 905–909 (1967).
Deckebs, P.J., Edgebton, B.W., Thomas, B.S., Pilch, Y.H.: The adoptive transfer of concomitant immunity to murine tumor isografts with spleen cells from tumor-bearing animals. Cancer Res. 31, 734–742 (1971).
Delobme, E.J., Alexandeb, P.: Treatment of primary fibrosarcoma in the rat with immune lymphocytes. Lancet 2, 117–120 (1964).
DeVbies, M. J., Vos, P.: Treatment of mouse lymphosarcoma by total body x-irradiation and by injection of bone marrow and lymph node cells. J. nat. Cancer Inst. 21, 1117–1129 (1958).
Djebassi, L: Transfusion of lymphocyte antibody and lymphocytes from multitransfused donors. Clin. Pediat. 7, 272–273 (1968).
Doll, R., Kinlen, L.: Immunological aspects of cancer — Part I. Immunosurveillance and cancer. Epidemiological evidence. Brit. med. J. 4, 420–422 (1970).
Editorial: Immunologic aspects of neoplasia. Cancer Bull. 22, 91–96 (1970).
Editorial: Immunotherapy of cancer. Med. J. Austral. 2, 289–291 (1971).
Edwabds, C.L., Congdon, C.C., Gengozian, N., Vodopick, H., Andbews, G.A.: Treatment of acute leukemia: An experimental immunologic approach. Exp. Hematol. 9, 23–24 (1966).
Elkins, W.L.: Cellular immunology and the pathogenesis of the graft-versus-host reactions. Progr. Allergy 15, 78–187 (1971).
Ellman, L., Gbeen, L: L2C guinea pig leukemia: Immunoprotection and immunotherapy. Cancer 28, 647–654 (1971).
Ellman, L., Katz, D.H., Gbeen J., Paul, W.E., Benacebbaf, B.: Mechanisms involved in the antileukemic effect of immunocompetent allogeneic lymphoid cell transfer. Cancer Res. 32, 141–148 (1972).
Evans, CA., Gobman, L.R., Ito, Y., Weiseb, R.S.: Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines. J. nat. Cancer Inst. 29, 277–285 (1962a).
Evans, C.A., Weiseb, R.S., Ito, Y.: Antiviral and antitumor immunologic mechanisms operative in the Shope papilloma-carcinoma system. Cold Spr. Harb. Symp. quant. Biol. 27, 453–462 (1962 b).
Evebson, T.C., Cole, W.H.: Spontaneous Regression of Cancer. Philadelphia: W. B. Saunders 1966.
Fairley, G.H.: Immunological aspects of cancer — II. Evidence for antigenicity in human tumours with reference to both melanoma and acute leukaemia. Brit. med. J. 4, 483–484 (1970).
Fairley, G.H., Ceowtheb, D., Guyeb, J.G., Habdisty, R.M., Kay, H.E.M., Knapton, P.J., McElwain, T.J., Pabb, I.B.: Active immunotherapy in the treatment of leukemia and other malignant diseases in animals and man. Rec. Results Cancer Res. 30, 138–141 (1970).
Fass, L., Fefeb, A.: Studies of adoptive chemoimmunotherapy of a Friend virus induced lymphoma. Cancer Res. 32, 997–1001 (1972a).
Fass, L., Fefer, A.: Application of an in vitro cytotoxicity test to studies of the effects of drugs on the cellular immune response in mice. I. Primary response. J. Immunol. 109, 749–753 (1972b).
Fass, L., Fefer, A.: Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma. Cancer Res., 32, 2427–2431 (1973).
Fass, L., Herberman, R.B., Ziegler, J., Morrow, R.H.: Evaluation of the effect of remission plasma on untreated patients with Burkitt lymphoma. J. nat. Cancer Inst. 44, 145–149 (1970).
Fefer, A.: Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice. Cancer Res. 29, 2177–2183 (1969).
Fefer, A.: Immunotherapy of primary Moloney sarcoma virus-induced tumors. Int. J. Cancer 5, 327–337 (1970).
Fefer, A.: Adoptive chemoimmunotherapy of a Moloney lymphoma. Int. J. Cancer 8, 364–373 (1971a).
Fefer, A.: Experimental approaches to immunotherapy of cancer. In: Current concepts in the management of leukemia and lymphoma. Rec. Results Cancer Res. 36, 182–192 (1971b).
Fefer, A.: Guest Editorial: Immunotherapy of cancer. J. nat. Cancer Inst. 47, VII–XII (1971c).
Fefer, A.: Adoptive tumor immunotherapy in mice as an adjunct to whole body x-irradiation or chemotherapy — A review. Israel J. med. Sci. 9, 350–365 (1973a).
Fefer, A.: Immunotherapy of cancer in mice. In: Frontiers Radiation Therapy Oncology, Vol. 7. pp. 35–49. Basel: S. Karger 1972.
Fefer, A.: Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells. Cancer Res. 33, 641–644 (1973b).
Fefer, A., Buckner, C.D., Clift, R.A., Fass, L., Lerner, K.G., Mickelson, E.M., Neiman, P., Rudolph, R., Storb, R., Thomas, E.D.: Marrow grafting in identical twins with hematologic malignancies. Transpl. Proc. 5, 927–931 (1973a).
Fefer, A., McCoy, J.L., Glynn, J.P.: Antigenicity of a virus-induced murine sarcoma (Moloney). Cancer Res. 27, 962–967 (1967a).
Fefer, A., McCoy, J.L., Glynn, J.P.: Induction and regression of primary Moloney sarcoma virus-induced tumors in mice. Cancer Res. 27, 1626–1631 (1967b).
Fefer, A., McCoy, J.L., Glynn, J. P.: Studies on the growth and regression of a transplantable Moloney sarcoma. Cancer Res. 27, 2207–2211 (1967 c).
Fefer, A., McCoy, J.L., Perk, K., Glynn, J.P.: Immunologic, virologie and pathologic studies of regression of autochthonous Moloney sarcoma virus (MSV)-induced tumors in mice. Cancer Res. 28, 1577–1585 (1968).
Fefer, A., Thomas, E. D., Buckner, C. D., Storb, R., Neiman, P., Glucksberg, H., Clift, R. A., Lerner, K.G.: Marrow Transplants in Aplastic Anemia and Leukemia. Seminars in Hematology, (1973b).
Fialkow, P.J., Thomas, E.D., Bryant, J.I., Neiman, P.E.: Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1, 251–255 (1971).
Fink, M.A., Rauscher, F.J.: Immune reactions to a murine leukemia virus. I. Induction of immunity to infection with virus in the natural host. J. nat. Cancer Inst. 32, 1075–1082 (1964).
Fisher, B., Saffer, E.A., Fisher, E.R.: Experiences with lymphocyte immunotherapy in experimental tumor systems. Cancer 27, 771–781 (1971).
Floersheim, G.L.: Facilitation of tumor growth by Bacillus pertussis. Nature (Lond.) 216, 1235–1237 (1967).
Floersheim, G.L.: Treatment of Moloney lymphoma with lethal doses of dimethyl myleran combined with injection of hemopoietic cells. Lancet 1, 228–233 (1969).
Frenster, J.H., Rogoway, W.M.: In vitro activation and reinfusion of autologous human lymphocytes. Lancet 2, 979–980 (1968).
Fridman, W. H., Kourilsky, E.M.: Stimulation of lymphocytes by autologous leukaemia cells in acute leukaemia. Nature (Lond.) 224, 277–279 (1969).
Girardi, A.J.: Tumor resistance and tumor enhancement with SV40 virus-induced tumors. Germinal Centers in Immune Responses. Proc. of a Symposium held at the University of Bern, Switzerland, June 22–24, 1966, pp. 422–427. Heidelberg: Springer-Verlag 1966.
Glasspiegel, J.S., Saltzstein, E.C., Rimm, A.A., Giller, R.H., Bortin, M.M.: Graft-versus-leukemia: Adoptive immunotherapy for the eradication of murine leukemia. Exp. Hematol. 21, 23–24(1971).
Glucksberg, H., Fefer, A.: Chemotherapy of established graft-versus-host (GVH) disease in mice. Transplantation 13, 300–305 (1972).
Glynn, J.P., Halpern, B.L., Fefer, A.: An immunochemotherapeutic model for the treatment of a transplanted Moloney virus-induced lymphoma in mice. Cancer Res. 29, 515–520 (1969).
Glynn, J.P., Kbnde, M.: Treatment of Moloney virus-induced leukemia with cyclophosphamide and specifically sensitized allogeneic cells. Cancer Res. 31, 1383–1388 (1971).
Glynn, J.P., McCoy, J. L., Fefer, A.: Cross-resistance to the transplantation of syngeneic Friend, Moloney and Rauscher virus-induced tumors. Cancer Res. 28, 434–439 (1968).
Gold, P.: The role of immunology in human cancer research. Canad. med. Ass. J. 103, 1043–1051 (1970).
Gold, P., Freedman, S.: Demonstration of tumor-specific antigens of the human colonic carcinomata by immunological tolerance and absorption techniques. J. exp. Med., 121, 439–462 (1965).
Goldner, H., Girardi, A.J., Larsen, D.M., Hilleman, M.R.: Interruption of SV40 virus tumorigenesis using irradiated homologous tumor antigens. Proc. Soc. exp. Biol. 117, 851–857 (1964).
Graham, J.B., Graham, R.M.: The effect of vaccine on cancer patients. Surg. Gynec. Obstet. 109, 131–138 (1959).
Graham, J. B., Graham, R.M.: Autogenous vaccine in cancer patients. Surg. Gynec. Obstet. 114, 1–4 (1962).
Graw, R.G. Jr., Herzig, G.P., Rogentine, G.N. Jr., Yankee, R.A., Leventhal, B., Whang-Peng, J., Halterman, R.H., Kruger, G., Berard, C., Henderson, E.S. Graftversus-host reaction complicating HL-A matched bone marrow transplantation. Lancet 2, 1053–1055 (1970).
Graw, R.G., Jr., Leventhal, B.G., Yankee, R.A., Rogentine, G.N., Wang-Peng, J., Ginnit, M.H., Herzig, G. P., Halterman, R.H., Henderson, E.S.: HL-A and mixed leukocyte culture matched allogeneic bone marrow transplantation in patients with acute leukemia. Transplant. Proc. 3, 405–408 (1971).
Graw, R.G., Jr., Santos, G.W.: Bone marrow transplantation in patients with leukemia. Incidence and severity of graft-versus-host disease in successful HL-A-matched transplants. Transplantation 11, 197–199 (1971).
Gross, L.: Tentative guidelines referring to inoculation of homologous cancer extracts in man. Int. J. Cancer 7, 182–185 (1971).
Guyer, R.J., Crowther, D.: Active immunotherapy in treatment of acute leukemia. Brit. med. J. 2, 406–407 (1969).
Haddow, A., Alexander, P.: An immunological method of increasing the sensitivity of primary sarcomas to local irradiation with x-ray. Lancet 1, 452–457 (1964).
Halpern, B.N., Biozzi, G., Steffel, C. Mouton, D.: Inhibition of tumor growth by administration of killed Corynebacterium parvum. Nature (Lond.) 212, 853–854 (1966).
Harel,J., Constantin, T.: Sur la malignité des tumeurs provoquées par le virus fibromateaux de Shope, chez le lapin nouveau-né et le lapin adulte traité par des doses massives de cortisone. Bull. Ass. Franc. Cancer 41, 483–489 (1954).
Havas, H.F., Donnelly, A.J.: Mixed bacterial toxins in the treatment of tumors. IV. Response of methylcholanthrene-induced, spontaneous, and transplanted tumors in mice. Cancer Res. 21, 17–25 (1961).
Havas, H.F., Groesbeck, M.E., Donnelly, A. J.: Mixed bacterial toxins in the treatment of tumors. I. Methods of preparation and effects on normal and sarcoma 37-bearing mice. Cancer Ites. 18, 141–148 (1958).
Hellstrom, I., Hellstrom, K.E., Pierce, G.E., Bill, A.H.: Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc. nat. Acad. Sci. (Wash.) 60, 1231– 1238 (1968).
Hellstrom, I., Hellstrom, K.E., Pierce, G.E., Fefer, A.: Studies on immunity to autochthonous mouse tumors. Transplant. Proc. 1, 90–94 (1969).
Hellstrom, I., Hellstrom, K.E., Sjogren, H. O.: Some recent information on “blocking antibodies” as studied in vitro. Transplant. Proc. 3, 1221–1227 (1971a).
Hellstrom, I., Hellstrom, K.E., Sjogren, H.O., Warner, G.A.: Serum factors in tumorfree patients cancelling the blocking of cell-mediated tumor immunity. Int. J. Cancer 8, 185–191 (1971b).
Hellstrom, I., Sjogren, H.O., Warner, G., Hellstrom, K.E.: Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int. J. Cancer 7, 226–237 (1971c).
Hellstrom, K.E., Hellstrom, L: Cellular immunity against tumor antigens. Adv. Cancer Res. 122, 167–223 (1969).
Hellstrom, K.E., Hellstrom, L: Some aspects of the immune defense against cancer. I. In vitro studies on animal tumors. Cancer 28, 1266–1268 (1971a).
Hellstrom, K.E., Hellstrom, L: Some aspects of the immune defense against cancer. II. In vitro studies on human tumors. Cancer 28, 1269–1271 (1971b).
Herberman, R., Rogentine, G.N., Oren, M.E.: Bioassay of antitumor effects of human alloantisera. Clin. Res. 17, 328 (1969).
Hill, G., Littlejohn, K., Kelly, G., Atkins, R., Greer, J., Eiseman, B.: Effects of pig leukocytes on mouse lymphatic leukemia. J. Surg. Oncol. 3, 569–579 (1971).
Horn, L., Horn, H.L.: An immunological approach to the therapy of cancer. Lancet 2, 465–469 (1971).
Hughes, L.E., Kearney, R., Tully, M.: A study in clinical cancer immunotherapy. Cancer 26, 269–278 (1970).
Humphrey, L.J.: Tumor immunity. J. surg. Res. 10, 493–512 (1970).
Humphery, L.J., Jewell, W.R., Murray, D.R., Griffen, W. O., Jr.: Immunotherapy for the patient with cancer. Ann. Surg. 173, 47–54 (1971a).
Humphrey, L.J., Murray, D.R., Boehm, O.R.: Effect of tumor vaccines in immunizing patients with cancer. Surg. Gyn. Obstet. 132, 437–442 (1971b).
Hunt, P.S.: Immunity in cancer. Aust. New Zeal. J. Surg. 40, 369–373 (1971).
Ikonopisov, R.L., Lewis, M.G., Hunter-Craig, I.D., Bodenham, D.C., Phillips, T.M., Cooling, C.I., Proctoer, J., Fairley, G.H., Alexander, P.: Autoimmunization with irradiated tumour cells in human malignant melanoma. Brit. med. J. 2, 752–754 (1970).
Israel, L., Mannoni, P., Mawas, C., Gineste, J., Gross, B., Sors, C.: 70 perfusions de lymphocytes homologues dans 25 cas de cancers avancés. Path. Biol. (Paris) 15, 603–606 (1967).
Izawa, T., Sakurai, M., Atsuta, Y., Yoshizumi, P.: Antigenicity of leukemia and antiserum therapy. Ann. Paediat. Jap. 12, 346–362 (1966).
Jagarlamoody, S.M., Aust, S.C., Tew, R.H., McKhann, C.F.: In vitro detection of cytotoxic cellular immunity against tumor specific antigens by a radioisotope technique. Proc. nat. Acad. Sci. (Wash.) 68, 1346–1350 (1971).
Jagarlamoody, S.M., McKhann, C.F.: Immunotherapy of cancer-current status. Geriatrics 25, 155–160 (1970).
James, K.W.: Tumor immunology and response to radiation therapy. Radiol. Clin. N. Amer. 7, 353–364 (1969).
Johnson, F.L.: Immunological aspects of malignant disease. Med. J. Aust. 2, 317–325 (1971).
Johnston, B. J.Clinical effect of Coley’s toxin — LA controlled study. Cancer Chemother. Rep. 21, 19–41 (1962).
Johnston, B.J., Novales, E.T.: Clinical effect of Coley’s toxin — IL A seven year study. Cancer Chemother. Rep. 21, 43–68 (1962).
Kaliss, N.: Immunological enhancement in tumor homografts in mice. A review. Cancer Res. 18, 992–1003 (1958).
Kaliss, N.: The elements of immunologic enhancement. A consideration of mechanisms. Ann. N. Y. Acad. Sci. 101, 64–79 (1962).
Katz, D.H., Ellman, L., Paul, W.E., Green, I., Benacerraf, B.: Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells. Cancer Res. 32, 133–140 (1972).
Keast, D.: Immunosurveillance and cancer. Lancet 2, 710–712 (1970).
Kellock, T.H., Chambers, H., Russ, S.: An attempt to procure immunity to malignant disease in man. Lancet 1, 217–219 (1922).
Klein, G.: Tumor antigens. Ann. Rev. Microbiol. 20, 223–252 (1966).
Klein, G.: Tumor-specific transplantation antigens. Cancer Res. 28, 625–635 (1968).
Klein, G.: Experimental studies in tumor immunology. Fed. Proc. 28, 1739–1753 (1969a).
Klein, G.: Hypersensitivity reactions at tumor sites. Cancer Res. 29, 2351–2362 (1969b).
Klein, G.: Immunological studies on a human tumor. Dilemmas of the experimentalist. Israel J. med. Sci. 7, 111–131 (1971a).
Klein, G.: Immunological studies on Burkitt’s lymphoma. Leukemia research fund lecture. Postgrad, med. J. 47, 141–155 (1971b).
Koldovsky, P.: An attempt at in vitro sensitization of immunologically competent cells against tumour specific antigens. Folia biol. (Praha) 12, 238–247 (1966).
Krementz, E.T., Samuels, M.T.: Tumor cross-transplantation and cross-transfusion in the treatment of advanced malignant disease. Bull. Tulane med. Fac. 26, 263–270 (1967).
Lappe, M.A.: Evidence for the antigenicity of papillomas induced by 3-methylcholanthrene. J. nat. Cancer Inst. 40, 823–846 (1968).
Laszlo, J., Buckley, C.E., III, Amos, B.D.: Infusion of isologous immune plasma in chronic lymphocytic leukemia. Blood 31, 104–110 (1968).
Law, L.W.: Studies of the significance of tumor antigens in induction and regression of neoplastic diseases. Cancer Res. 29, 1–21 (1969).
Law, L. W., Ting, R. C., Leckband, E.: Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells. Proc. nat. Acad. Sci. (Wash.) 57, 1068–1075 (1967).
Law, L.W., Ting, R.C., Stanton, M.S.: Some biologiC., immunogenic and morphologic effects in mice after infection with murine sarcoma virus. I. Biologic and immunogenic studies. J. nat. Cancer Inst. 40, 1101–1112 (1968).
Lemonde, P., Clode-Hydb, M.: Influence of Bacillus Calmette-Guerin infection on polyoma in hamsters and mice. Cancer Res. 26, 586–589 (1966).
Leukemia Committee: Treatment of acute lymphoblastic leukemia: Comparison of immuno-therapy (BCG) — intermittent methotrexate on therapy after a 5-month intermittent cytotoxic regimen. (Concord Trial.) Brit. med. J. 4, 189–194 (1971).
Leyden, E. von, BlumenthalF, F.: Attempts to immunize humans by inoculation of their own cancer. Deutsch. Med. Wschr. 28, 637–638 (1902).
Mackler, B.F.: Role of soluble lymphocyte mediators in malignant-tumour destruction. Lancet 2, 297–301 (1971).
Malkiel, S., Hargis, B. J.: Influence of B pertussis on host survival following S-180 implantation. Cancer Res. 21, 1461–1464 (1961).
Mardiney, M.R., Jr., Block, J.B., Serpick, A.A.: Immunotherapy for leukemia: Quantitative aspects and adjuvant relationship to chemotherapy. Cancer Chemother. Rep. 53, 3–12 (1969).
Martin, D.S., Hayworth, P.E., Fugman, R.A.: Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy and immunotherapy. Cancer Res. 30, 709–716 (1970).
Martin, W.J., Wunderlich, J.R., Fletcher, F., Inman, J.K.: Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc. nat. Acad. Sci. (Wash.) 68, 469–472 (1971).
Mathé, G.: Immunotherapie active de la leucémie L1210 appliquées après la greffe tumorale. Rév. Franc. Étud. clin. Biol. 13, 881–883 (1968).
Mathé, G.: Immunological aspects of cancer — II. Immunological treatment of leukaemias. Brit. med. J. 4, 487–488 (1970).
Mathé, G.: Active immunotherapy. Adv. Cancer Res. 14, 1–36 (1971a).
Mathé, G.: Immunotherapy in the treatment of acute lymphoid leukemia. Hosp. Pract. 6, 43–51 (1971b).
Mathé, G., Amiel, J.L., Bernard, J.: Traitement de souris AKR à Tage de six mois par irradiation totale suivie de transfusion de cellules hématopoiétiques allogéniques incidences respectives de la leucémie et du syndrome secondaire. Bull. Cancer 47, 331–340 (1960).
Mathé, G., Amiel, J.L., Niemetz, J.: Greffe de moelle osseuse après irradiation totale chez des souris leucémiques suivie de l’administration d’un antimitotique pour réduire la fréquence du syndrome secondaire et ajouter à l’effet antileucémique. C. R. Acad. Sci. (Paris) 254, 3603–3605 (1962).
Mathé, G., Amiel, J.L., Schwarzenberg, L., Cattan, A., Schneider, M., DeVries, M.J., Tubiana, M., Lalanne, C., Binet, J.L., Papeirnik, M., Seman, G., Matsukura, M., Schwarzmann, V., Flaisler, A.: Successful allogeneic bone marrow transplantation in man: Chimerism, induced specific tolerance and possible antileukemic effects. Blood 25, 179–196 (1965).
Mathé, G., Amiel, J. L., Schwarzenberg, L., Schneider, M., Cattan, A., Schlumburger, A.R., Hayat, M., De Vassal, F.: Active immunotherapy for acute lymphoblastic leukemia. Lancet 1, 697–699 (1969a).
Mathé, G., Bernard, J.: Essai de traitement, par l’irradiation X suivie de l’administration de cellules myeloides homologues, de souris AK atteintes de leucémie spontanée très avancée. Bull. Cancer 45, 289–300 (1958).
Mathé, G., Bevnase, J.: Essai de traitement de la leucémie greffe L1210 par l’irradiation X suivie de transfusions de cellules hématopoiétique normales. Rév. Franc. Étud. clin. Biol. 4, 442–446 (1959).
Mathé, G., Pouillart, P.: Active immunotherapy of L1210 leukemia applied after the graft of tumor cells. Rec. Results Cancer Res. 30, 64–75 (1970).
Mathé, G., Pottillart, P., Lapeyraque, F.: Active immunotherapy of L1210 leukemia applied after the graft of tumor cells. Brit. J. Cancer 23, 814–824 (1969b).
Mathé, G., Schwarzenberg, L., Amiel, J.L., Pottillart, P., Schneider, M., Cattan, A.: Experimental basis and clinical results of leukemia adoptive immunotherapy. Rec. Results Cancer Res. 30, 76–84 (1970).
Matsuyama, M., Maekawa, A., Hordxawa, H., Suzumori, K., Sogal, K., Iwai, K.: Ineffectiveness of autotransplantation on growth of the methylcholanthrene sarcoma in rats and mice. Nature (Lond.) 197, 805–807 (1963).
McCoy, J.L., Fefer, A., Glynn, J.P.: Comparative studies on the induction of transplantation resistance in BALB/c and C57B1/6 mice in three murine leukemia systems. Cancer Res. 27, 1743–1748 (1967 a).
McCoy, J.L., Fefer, A., Glynn, J.P.: Influence of infectious virus on the induction of transplantation resistance in the Friend tumor system. Cancer Res. 27, 2267–2271 (1967 b).
McCoy, J.L., Fefer, A., Glynn, J.P.: Inhibition and enhancement of syngeneic Friend virus-induced lymphoma cells by passively transferred anti-Friend serum. Exp. Hematol. 16, 24–26 (1968).
McCoy, J.L., Fefer, A., McCoy, N.T., Kirsten, W.H.: Iminunobiologic studies of tumors induced by murine sarcoma virus (Kirsten). Cancer Res. 32, 343–349 (1972a).
McCoy, J.L., Fefer, A., Ting, B.C., Glynn, J.P.: The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults. Cancer Res. 1671–1678 (1972b).
McCredie, J.A., Brown, E.R., Cole, W.H.: Immunologic treatment of tumors. Proc. Soc. exp. Biol. (N. Y.) 100, 31–33 (1959).
McEnany, M.T., Kelly, M.G., Fahey, J.L.: Effects of immunization with tumor-cell-foreign- protein conjugates on growth of syngeneic tumor grafts. Proc. Amer. Ass. Cancer Res. 9, 46 (1968).
McPeak, C.J.: Intralymphatic therapy with immune lymphocytes. Cancer 28, 1126–1128 (1971).
Mihich, E.: Combined effects of chemotherapy and immunity against leukemia L1210 in DBA/2 mice. Cancer Res. 29, 848–854 (1969).
Mikulska, Z.B., Smith, C., Alexander, P.: Evidence for an immunological reaction of the host directed against its own actively growing primary tumor. J. nat. Cancer Jnst. 36, 29–35 (1966).
Miles, A. E.: The immunological treatment of malignant disease. S. Air. med. J. 44, 1116–1119 (1970).
Mitchison, N.A.: Immunologic approach to cancer. Transplant. Proc. 2, 92–103 (1971).
Moller, G.: The effects on tumor growth in syngeneic recipients of antibodies against tumor-specific antigens in methylcholanthrene-induced mouse sarcomas. Nature (Lond.) 204, 846–847 (1964).
Moore, G.E., Gerner, R.E.: Cancer immunity-hypothesis and clinical trial of lymphocyto-therapy for malignant disease. Ann. Surg. 172, 733–739 (1970).
Morton, D.L.: Immunological aspects of neoplasia: A rational basis for immunotherapy. Ann. int. Med. 74, 587–604 (1971).
Morton, D.L., Eilber, F.R., Joseph, W.L., Wood, W.C., Traban, E., Ketcham, S.: Immuno-logical factors in human sarcomas and melanomas. A rational basis for immunotherapy. Ann. Surg. 172, 740–749 (1970).
Motta, R.: Passive immunotherapy of leukemia and other cancer. Adv. Cancer Res. 14, 161–179 (1971).
Murray, G.: Experiments in immunity in cancer. Canad. med. Assoc. J. 79, 249–259 (1958).
Nadler, S. H., Moore, G. E.: Immunotherapy of malignant melanoma. Geriatrics. 23, 150–153 (1968).
Nadler, S.H., Moore, G.E.: Immunotherapy of malignant disease. Arch. Surg. 99, 376–381 (1969).
Nadler, S.H., Moore, G.E.: Response to injection of cultured human tumor cells. Arch. Surg. 100, 244–248 (1970).
Nagel, G.A., Arneault, G.S., Holland, J.F., Kirkpatrick, D., Kirkpatrick, R.: Cell-mediated immunity against malignant melanoma in monozygous twins. Cancer Res. 30, 1828–1832 (1970).
Natale, N., Reiner, J., Southam, C.M.: Immunogenic efficacy of various syngeneic tumor cell preparations. Cancer 28, 1118–1125 (1971).
Neiman, P., Wasserman, P.B., Wentworth, B.B., Kao, G.F., Lerner, K.G., Storb, R., Buckner, C.D., Clift, R.A., Fefer, A., Fass, L., Glucksberg, H., Thomas, E.D.: Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation 15, 478–485 (1973).
Newton, W.T., Donaldson, R.C.: Lymph transfusion in patients with cancer. Amer. J. Surg. 118, 988–991 (1969).
Ngu, V.: Host defences to Burkitt tumours. Brit. med. J. 1, 345–347 (1967).
Oettgen, H.F., Old, J.L., Boyse, E.A.: Human tumor immunology. Med. Clin. N. Amer. 55, 761–785 (1971).
Old, L.J., Benacerraf, B., Clarke, D. A., Carswell, E.A., Stockert, E.: The role of the reticuloendothelial system in the host reaction to neoplasia. Cancer Res. 121, 1281–1300 (1961).
Old, L.J., Boyse, E.A.: Immunology of experimental tumors. Ann. Rev. Med. 15, 167–186 (1964).
Old, L.J., Boyse, E.A.: Prospects for immunotherapy of human cancer. Ann. int. Med. 69, 393–396 (1968).
Old, L.J., Boyse, E.A., Clarke, D.A., Carswell, E.A.: Antigenic properties of chemically induced tumors. Ann. N. Y. Acad. Sci. 101, 80–106 (1962).
Old, L. J., Clarke, D. A., Benacerraf, B.: Effect of Bacillus Calmette-Guerin (BCG) infection on transplanted tumors in the mouse. Nature (Lond.) 184, 291–292 (1959).
Old, L.J., Stockest, E., Boyse, E.A., Geebing, G.: A study of passive immunization agains a transplanted G+ leukemia with specific antigens. Proc. Soc. exp. Biol. (N. Y.) 124, 63–68 (1967).
Owens, A. H.,Jr., Santos, G. W.: The effect of cyclophosphamide and allogeneic and parental spleen cells on the course of L1210 leukemia. Exp. Hemat. 8, 15–17 (1965).
Owens, A.H., Jr., Santos, G.W.: The effect of cytotoxic drugs on graft-versus-host disease in mice. Transplantation 11, 378–382 (1971).
Penn, L. Malignant tumors in organ transplant recipients. Bee. Results Cancer Res. 35, 1–51 (1970).
Piessens, W.F.: Evidence for human cancer immunity. A review. Cancer 26, 1212–1220 (1970).
Piessens, W.F., Hediann, R., Legeos, N., Heuson, J.: Effect of Bacillus Calmette-Guerin on mammary tumor formation and cellular immunity in dimethylbenz(a)anthracene-treated rats. Cancer Res. 31, 1061–1065 (1971a).
Piessens, W.F., Heimann, R., Legeos, N., Heuson, J.: Effects of Bacillus Calmette-Guerin (BCG) infection on residual disease of the rat mammary tumor after ovariectomy. Europ. J. Cancer 7, 377–380 (1971b).
Piessens, W.F., Lachapelle, F.L., Legeos, N., Heuson, J.: Facilitation of rat mammary tumour growth by BCG. Nature (Lond.) 228, 1210–1211 (1970).
Pilch, Y.H., Ramming, K.P.: Transfer of tumor immunity with ribonucleic acid. Cancer 26, 630–637 (1970).
Pilch, Y.H., Ramming, K.P., Decrees, P.J.: Transfer of tumor immunity with RNA. Israel J. med. Sci. 7, 246–258 (1971).
Pollack, S. B.: Effect of host sex and splenectomy on Moloney virus-induced sarcomas. Int. J. Cancer 8, 264–271 (1971).
Powles, R.L., Balchin, L.A., Fatbley, H., Alexandee, P.: Recognition of leukaemia cells as foreign before and after autoimmunization. Brit. med. J. 1, 486–489 (1971).
Rhodes, E.L.: An attempt to obtain autoimmunity to tumors with Freund’s adjuvant and tetanus toxoid. Nature (Lond.) 193, 1091 (1962).
Rios, A., Simmons, R.L.: Comparative effect of mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice. Cancer Res. 32, 16–21 (1972).
Rosenau, W., Moeton, D.L.: Tumor-specific inhibition of growth of methylcholanthrene-induced sarcomas in vivo and in vitro by sensitized isologous lymphoid cells. J. nat. Cancer Inst. 36, 825–836 (1966).
Rosenthal, S.R.: BCG in cancer and leukemia. Bull. Inst. Pasteur 70, 29–50 (1972).
Rubin, J.: The immunological basis for non-infective Rous sarcomas. Cold Spr. Harb. Symp. quant. Biol. 27, 441–452 (1962).
Rudolph, R.H., Fefee, A., Thomas, E.D., Bucknee, C.D., Cleft, R.A., Stoeb, R.: Isogeneic marrow grafts for hematologic malignancy in man. Arch. int. Med. 132, 279–285 (1973).
Salmon, S. E., Deakauee, R. S., Whitmoee, W.F.: Lymphocyte stimulation. Selective destruction of cells during blastogenic response to transplantation antigens. Science 172, 490–492 (1971).
Sanfoed, B.H.: An alteration in tumor histocompatibility induced by neuraminidase. Transplantation 4, 1273–1279 (1967).
Sanfoed, B.H., Codington, J. F.: Further studies on the effect of neuraminidase on tumor cell transplantability. Tissue Antigens 1, 153–161 (1971).
Santos, G.W.: Effect of graft-versus-host disease on a spontaneous adenocarcinoma. Exp. Hematol. 20, 46–48 (1970a).
Santos, G.W.: Immunologic concepts and their potential role in cancer therapy. Postgrad. Med. 48, 194–198 (1970b).
Santos, G.W.: Application of marrow grafts in human disease. Amer. J. Path. 65, 653–668 (1971).
Saetoeelli, A.C., LePage, G.A.: Modification of thioguanine toxicity in tumor-bearing mice with bone marrow transplants. Proc. Amer. Ass. Cancer Res. 26, 246 (1957).
Schwaetz, D.B., Zbae, B., Gibson, W.T., Chieigos, M.A.: Inhibition of murine sarcoma virus oncogenesis with living BCG. Int. J. Cancer 8, 320–325 (1971).
Schwaezenbeeg, L., Mathe, G., Schneidee, M., Amiel, J. L., Cattan, A., Schlumbueger, J. R.: Attempted adoptive immunotherapy of acute leukemia by leukocyte transfusions. Lancet 2, 365–368 (1966).
Shachat, D.A., Fefer, A., Moloney, J. B.: Effect of cortisone on oncogenesis by murine sarcoma virus (Moloney). Cancer Res. 28, 517–520 (1968).
Simmons, R.L., Rios, A.: Immunotherapy of cancer: Immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG. Science 174, 591–593 (1971).
Simmons, R. L., Rios, A., Lungren, G., Ray, P.K., McKhann, C.F., Haywood, G.R.: Immuno-specific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. Surgery 70, 38–46 (1971a).
Simmons, R.L., Rios, A., Ray, P.K., Lundgren, G.: Effect of neuraminidase on the growth of methylcholanthrene fibrosarcoma in normal and immunosuppressed syngeneic mice. J. nat. Cancer Inst. 47, 1087–1094 (1971b).
Sjogren, H.O., Ankerst, J.: Effect of BCG and allogeneic tumor cells on adenovirus Type 12 tumorigenesis in mice. Nature (Lond.) 221, 863–864 (1969).
Sjogren, H.O., Borum, K.: Tumor-specific immunity in the course of primary polyoma and Rous tumor development in intact and immunosuppressed rats. Cancer Res. 31, 890–988 (1971).
Skurkovich, S.V., Kisljak, N.S., Machonova, L.A., Begunenko, S. A.: Active immunization of children suffering from acute leukemia in acute phase with live allogeneic leukemic cells. Nature (Lond.) 223, 509–511 (1969a).
Skurkovich, S.V., Machonova, L.A., Reznichenko, F.M., Chervonsky, G.L: Treatment of children with acute leukemia by passive cyclic immunization with autoplasma and autoleukocytes operated during the remission period. Blood 33, 186–197 (1969b).
Smith, R.T.: Tumor-specific immune mechanisms. New Engl. J. Med. 278, 1207–1214, 1268–1275 and 1326–1331 (1968).
Sophocles, A.M., Nadler, S.H.: Immunologic aspects of cancer. Surg. Gyn. Obst. 133, 321–331 (1971).
Southam, C.M.: Immunotherapy of sarcoma patients. Frontiers of Radiation Therapy and Oncology, Vol. 7. Basel: Karger 1972.
Sparck, J.V., Volkert, M.: Effect of adoptive immunity on experimentally-induced leukemia in mice. Nature (Lond.) 206, 578–579 (1965).
Starzl, T.E., Penn, I., Halgrimson, C.G.: Immunosuppression and malignant neoplasms. New Engl. J. Med. 283, 934–935 (1970).
Store, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Johnson, F.L., Fefer, A., Glucksberg, H., Giblett, E.R., Lerner, K.G., Neiman, P.: Allogeneic Marrow Grafting for Treatment of Aplastic Anemia. Blood, 43, 157–180 1973.
Sumner, W.C., Foraker, G.: Spontaneous regression of human melanoma, clincal and experimental studies. Cancer 13, 79–81 (1960).
Symes, M.O.: Immunological problems in the treatment of malignant disease. Proc. roy. Soc. Med. 63, 135–136 (1970).
Symes, M.O., Riddell, A.G.: Immunologically competent cells in the treatment of malignant disease. Lancet 1, 1054–1056 (1968).
Thomas, E.D., Bryant, J.I., Buckner, C.D., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P., Ramberg, R.E., Storb, R.: Leukaemic transformation of engrafted human marrow cells in-vivo. II. Lancet I: 1310–1313 (1972a).
Thomas, E.D., Buckner, C.D., Rudolph, R.H., Fefer, A., Storb, R., Neiman, P.E., Bryant, J.I., Chard, R.L., Clift, R.A., Epstein, R.B., Fialkow, P. J., Funk, D.D., Giblett, E.R., Lerner, K.G., Reynolds, R. A., Slichter, S.: Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairs. Blood 38, 267–287 (1971).
Thomas, E.D., Buckner, C.D., Clift, R.A., Fass, L., Fefer, A., Lerner, K.G., Neiman, P., Rowley, N., Storb, R.: Marrow grafting in patients with acute leukemia. Transpl. Proc. 5, 917–922 (1973).
Thomas, E.D., Buckner, C.D., Storb, R., Neiman, P.E., Fefer, A., Clift, R.A., Slichter, S. J., Funk, D.D., Bryant, J.I., Lerner, K.E.: Aplastic anemia treated by marrow transplantation. Lancet I, 284–289 (1972b).
Thomas, E.D., Herman, E.C., Jr., Greenough, W.B., III, Hager, E.B., Cannon, J.H., Sahler, O.D., Ferrebee, J.W.: Irradiation and marrow infusion in leukemia. Arch. int. Med. 107, 829–845 (1961).
Thomas, E.D., Lochte, H.L., Cannon, J.H., Sahler, O.D., Ferrebee, J.W.: Supralethal whole-body irradiation and isologous marrow transplantation in man. J. clin. Invest. 38, 1709 (1959).
Thomson, D.M.P., Krupey, J., Freedman, S.O., Gold, P.: The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc. nat. Acad. Sci. (Wash.) 64, 161–167 (1969).
Trentin, J. J.: Whole body x-ray and bone marrow therapy of leukemia in mice. Proc. Amer. Assoc. Cancer Res. 2, 54 (1957).
Vadlamudi, S., Padarathsingh, M., Bonmassar, E., Goldin, A.: Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (L1210) mice. Int. J. Cancer 7, 160–166 (1971).
Vanbekkum, D.W., DeVries, M.J.: Radiation chimeras. London: Logos Press (1967).
Varet, B., Levy, J.P., Leclbec, J.C., Senik, A.: Rôle de l’immunité dans le rejet des tumeurs induites par le virus MSV. Effect des serums antithymocytes. Int. J. Cancer 3, 727–733 (1968).
Villasor, R.: The clinical use of BCG vaccine in stimulating host resistance to cancer. Philipp. med. Assoc. 41, 619–632 (1965).
Viza, D., Davies, D.A.L., Tood, R., Bernard-Degani, R., Bernard, C., Harris, R.: Mise en évidence, isolement et purification partielle d’antigènes leucémiques chez l’homme. Presse Med. 78, 2259–2264 (1970).
Wagner, H., Rollinghoff, M.: In Vitro Induction of Tumor-Specific Immunity. J. exp. Med., 138, 1–15 (1973).
Wahren, B.: Immunotherapy in Friend virus leukemia. II. Prevention of Friend leukemia by passive administration of immune serum and cells to young mice. J. nat. Cancer Inst. 41, 931–938 (1968).
Weiss, D.W., Bonhag, R.S., Deome, K.R.: Protective activity of fractions of tubercule bacilli against isologous tumors in mice. Nature (Lond.) 190, 889–891 (1961).
Weiss, D.W., Bonhag, R.S., Leslie, P.: Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attentuated tubercle bacilli (BCG). II. Protection against tumor isografts. J. exp. Med. 124, 1039–1065 (1966).
Williams, A.C., Klein, E.: Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer 25, 450–462 (1970).
Woodruff, M.: Immunological aspects of cancer. II. Immunotherapy of cancer. Brit. med. J. 4, 486–487 (1970).
Woodruff, M.F.A., Boak, J.L.: Inhibitory effect on pre-immunized CBA spleen cells on transplants of A-strain mouse mammary carcinoma in (CBA × A) F 1 hybrid recipients. Brit. J. Cancer 19, 411–417 (1965).
Woodruff, M.F.A., Boak, J.L.: Inhibitory effect of injections of Corynebacterium parvum on the growth of tumor transplants in isogeneic hosts. Brit. J. Cancer 20, 345–352 (1966).
Woodruff, M.F.A., Nolan, B.: Preliminary observations on treatment of advanced cancer by injection of allogeneic spleen cells. Lancet 2, 426–429 (1963).
Woodruff, M.F.A., Symes, M. O.: The use of immunologically competent cells in the treatment of cancer. Experiments with a transplantable mouse tumor. Brit. J. Cancer 16, 707–715 (1962).
Woodruff, M.F.A., Symes, M.O., Anderson, N.F.: The effect of intraperitoneal injection of thoracic duct lymphocytes from normal and immunized rats in mice inoculated with the Landschutz ascites tumour. Brit. J. Cancer 17, 482–487 (1963 a).
Woodruff, M.F.A., Symes, M.O., Stuart, A.E.: The effect of rat spleen cells on two transplanted mouse tumours. Brit. J. Cancer 17, 320–327 (1963b).
Yashphe, D.J.: Immunological factors in nonspecific stimulation of host resistance to syngeneic tumors. A review. Israel J. med. Sci. 7, 90–107 (1971).
Zbar, B., Bernstein, I.D., Rapp, H.J.: Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guerin. J. nat. Cancer Inst. 46, 831–839 (1971).
Zbar, B., Tanaka, T.: Immunotherapy of cancer. Regression of tumors after intralesional injection of living Mycobacterium bovis. Science 172, 271–273 (1971).
Zoschke, D.C., Bach, F.H.: Specificity of allogeneic cell recognition by human lymphocytes in vitro. Science 172, 1350–1352 (1971).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Fefer, A. (1974). Tumor Immunotherapy. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive